Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines.
D000284:Administration, Oral; D000818:Animals; D017252:CD3 Complex / Q000276:immunology / Q000378:metabolism; D016923:Cell Death; D002686:Chitin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D048271:Chitosan; D024043:Collagen Type II / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D016207:Cytokines / Q000096:biosynthesis* / Q000235:genetics; D005260:Female; D015870:Gene Expression; D018928:Immunity, Mucosal; D016753:Interleukin-10 / Q000032:analysis; D007376:Interleukin-2 / Q000032:analysis; D010434:Pepsin A / Q000037:antagonists & inhibitors / Q000737:chemistry; D010581:Peyer's Patches / Q000276:immunology; D012333:RNA, Messenger; D051381:Rats; D017208:Rats, Wistar; D013154:Spleen / Q000166:cytology / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism
D017252:CD3 Complex; D024043:Collagen Type II; D016207:Cytokines; D007376:Interleukin-2; D012333:RNA, Messenger; D016753:Interleukin-10; D002686:Chitin; D048271:Chitosan; D010434:Pepsin A